Page last updated: 2024-11-11

3-aminopropylphosphinic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-aminopropylphosphinic acid: structure given in first source; selective GABA receptor agonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6335948
CHEMBL ID112203
SCHEMBL ID341549
MeSH IDM0170259

Synonyms (38)

Synonym
gtpl1081
PDSP1_001484
(3-aminopropyl)phosphinic acid
chembl112203 ,
3-aminopropylphosphinic derivative, 1
cgp27492
bdbm24184
PDSP2_001468
cgp 27492
3-aminopropylphosphinic acid
3-aminopropanephosphinic acid
phosphinic acid, (3-aminopropyl)
cgp 27 492
103680-47-3
cgp-27492
3-aminopropyl-hydroxy-oxophosphanium
3-appa
qmt5ss3qre ,
unii-qmt5ss3qre
cgp 27,492
AKOS006337792
[3h]3-appa
[3h]-cgp27492
[3h]-3-appa
gtpl5381
[3h]cgp27492
(3-aminopropyl)(hydroxy)oxo-$l^{5}-phosphanylium
SCHEMBL341549
(3-amino-propyl)-phosphinic acid
ZTHNRNOOZGJLRR-UHFFFAOYSA-N
CS-0255598
Q27073721
HY-115763
A849793
DTXSID201336775
cga-147823
phosphinic acid, p-(3-aminopropyl)-
aminopropylphosphinic acid, 3-

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In fact it showed: (1) very sensitive dose-response not affected by TTX in the bath; (2) an equilibrium potential compatible with Cl-channel conductance; (3) a massive reduction with the competitive GABA(A) antagonist bicuculline; (4) a small reduction, if any, with the potent competitive GABA(B) antagonist CGP55845A; (5) persistence of the responses under 4-AP (4-aminopyridine), the potassium channel blocker, and inhibition of the 4-AP-induced calcium bursts of spikes."( Purkinje cell inhibitory responses to 3-APPA (3-aminopropylphosphinic acid) in RAT cerebellar slices.
Batini, C; Vigot, R, 1999
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Gamma-aminobutyric acid type B receptor subunit 2Rattus norvegicus (Norway rat)IC50 (µMol)0.00520.00001.01016.8100AID71394; AID71401
Gamma-aminobutyric acid type B receptor subunit 2Rattus norvegicus (Norway rat)Ki0.01500.00510.06830.2200AID1798404
Gamma-aminobutyric acid type B receptor subunit 1Rattus norvegicus (Norway rat)IC50 (µMol)0.00510.00001.05326.8100AID71394; AID71401
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (26)

Assay IDTitleYearJournalArticle
AID36317Inhibition [3H]- prazosin binding to Alpha-1 adrenergic receptor at 10e-5 M1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
AID88556The compound was tested for blockade of the monosynaptic reflexes in the hemisected neonatal spinal cord1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
AID626682Agonist activity against human GABAB receptor expressed in HEK cells assessed as increase in cytoplasmic calcium level2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Discovery of a novel potent GABA(B) receptor agonist.
AID211502Inhibition of [3H]-substance P binding to Tachykinin receptor 1 at 10e-5 M1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
AID41897Inhibition of [3H]- DHA binding to Beta adrenergic receptor at 10e-5 M1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
AID339809Agonist activity at human recombinant GABABreceptor expressed in CHO-K1 cells assessed as inhibition of intracellular calcium release by FLIPR2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Synthesis and pharmacological evaluation of novel gamma-aminobutyric acid type B (GABAB) receptor agonists as gastroesophageal reflux inhibitors.
AID71394Inhibition of binding of [3H]CGP-27492 to gamma-aminobutyric acid type B receptor of rat cortex.1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 2. Selective, orally active GABAB antagonists.
AID87688Inhibition of [3H]- doxepine binding to histamine 1 receptor at 10e-5 M1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
AID71401Inhibition of [3H]CGP-27492 binding to Gamma-aminobutyric acid type B receptor of rat cortex1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
AID233587Ratio of IC50 for GABA-B and GABA-A receptors1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
AID152089Inhibition of [3H]- naloxone binding to mu-opiate receptor at 10e-5 M1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
AID339810Intrinsic activity at human recombinant GABAB receptor expressed in CHO-K1 cells assessed as inhibition of intracellular calcium release by FLIPR relative to GABA2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Synthesis and pharmacological evaluation of novel gamma-aminobutyric acid type B (GABAB) receptor agonists as gastroesophageal reflux inhibitors.
AID3453Inhibition of [3H]- 5-HT binding to 5-hydroxytryptamine 1 receptor at 10e-5 M1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
AID40989Inhibition of [3H]- flunitrazepam binding to GABA-A benzodiazepine receptor at 10e-5 M1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
AID175288Enhanced electrically induced release of [3H]GABA from rat cortical slices; agonist1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 2. Selective, orally active GABAB antagonists.
AID72586Inhibition of [3H]- muscimol binding to Gamma-aminobutyric acid A (GABA-A) receptor at 10e-5 M1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
AID175515Deterioration of rotarod performance of rats 0.5-1 hour after subcutaneous administration of compound1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
AID196573The compound was tested for inhibition of release of [3H]GABA from rat cortical slices after electrical stimulation.1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
AID30360Inhibition of [3H]- N-6-CA binding to Adenosine A1 receptor at 10e-5 M1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
AID339808Displacement of [3H]GABA from GABABreceptor in rat brain synaptic membranes2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Synthesis and pharmacological evaluation of novel gamma-aminobutyric acid type B (GABAB) receptor agonists as gastroesophageal reflux inhibitors.
AID71258Inhibition of [3H]-baclofen binding to Gamma-aminobutyric acid type B receptor of cat cerebellum1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
AID142909Inhibition of [3H]CMD binding to muscarinic ACh receptor at 10e-5 M1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
AID5132Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 10e-5 M1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
AID71997Inhibition of [3H]muscimol binding to GABA-A receptor of rat cortex1995Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17
Phosphinic acid analogues of GABA. 1. New potent and selective GABAB agonists.
AID1798404[3H]GABA Filtration Binding Assay (Ki) and FLIPR Assay for Agonism (EC50) from Article 10.1021/jm701425k: \\Synthesis and pharmacological evaluation of novel gamma-aminobutyric acid type B (GABAB) receptor agonists as gastroesophageal reflux inhibitors.\\2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Synthesis and pharmacological evaluation of novel gamma-aminobutyric acid type B (GABAB) receptor agonists as gastroesophageal reflux inhibitors.
AID1346001Rat GABAB1 (GABAB receptors)1997Nature, Mar-20, Volume: 386, Issue:6622
Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (3.33)18.7374
1990's24 (80.00)18.2507
2000's3 (10.00)29.6817
2010's2 (6.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.61 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index6.05 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]